Copyright
©The Author(s) 2020.
World J Gastroenterol. Nov 28, 2020; 26(44): 6929-6944
Published online Nov 28, 2020. doi: 10.3748/wjg.v26.i44.6929
Published online Nov 28, 2020. doi: 10.3748/wjg.v26.i44.6929
Table 1 Patient characteristics and univariate analysis
Characteristic | n | Disease-free survival | Overall survival | ||||
Time (mo) | P value | F | Time (mo) | P value | F | ||
Age, median, yr | 0.14 | 2.17 | 0.20 | 1.72 | |||
≥ 60 | 107 | 42.46 | 49.39 | ||||
< 60 | 93 | 50.48 | 55.79 | ||||
Gender | 0.15 | 2.10 | 0.12 | 2.42 | |||
Male | 142 | 43.86 | 50.23 | ||||
Female | 58 | 49.58 | 54.82 | ||||
Bormann type | 0.00 | 44.98 | 0.00 | 43.62 | |||
I | 15 | 69.93 | 69.93 | ||||
II | 88 | 45.57 | 51.73 | ||||
III | 94 | 29.35 | 36.99 | ||||
IV | 3 | 15.33 | 25.00 | ||||
Tumor size | 0.00 | 28.46 | 0.00 | 27.42 | |||
≥ 5 cm | 87 | 31.51 | 39.48 | ||||
< 5 cm | 113 | 57.46 | 62.07 | ||||
Location | 0.09 | 4.91 | 0.13 | 4.11 | |||
Upper | 44 | 35.22 | 43.33 | ||||
Middle | 56 | 49.33 | 54.92 | ||||
Low | 100 | 48.92 | 54.31 | ||||
Lauren type | 0.62 | 0.96 | 0.63 | 0.93 | |||
Intestinal | 95 | 45.22 | 51.26 | ||||
Mixed | 45 | 41.08 | 47.06 | ||||
Diffuse | 60 | 50.23 | 56.12 | ||||
Tumor differentiation | 0.16 | 2.00 | 0.19 | 1.71 | |||
Moderate and well | 66 | 50.80 | 56.28 | ||||
Poor | 134 | 44.57 | 50.74 | ||||
Vessel invasion | 0.00 | 16.30 | 0.00 | 14.73 | |||
Yes | 59 | 31.07 | 38.83 | ||||
No | 141 | 52.08 | 57.54 | ||||
Perineural invasion | 0.00 | 11.24 | 0.00 | 11.52 | |||
Yes | 51 | 28.01 | 37.39 | ||||
No | 149 | 52.14 | 57.41 | ||||
TNM stage | 0.00 | 335.89 | 0.00 | 360.28 | |||
I | 42 | 66.45 | 66.50 | ||||
II | 47 | 64.36 | 68.85 | ||||
III | 109 | 18.70 | 28.50 | ||||
IV | 2 | 5.00 | 8.50 | ||||
AC007991.4 | 0.05 | 3.77 | 0.05 | 3.95 | |||
Overexpression | 68 | 53.02 | 58.07 | ||||
Weak expression | 132 | 42.70 | 49.24 | ||||
AC079385.3 | 0.00 | 14.23 | 0.00 | 14.71 | |||
Overexpression | 95 | 36.26 | 43.94 | ||||
Weak expression | 105 | 55.12 | 59.92 | ||||
AL109615.2 | 0.00 | 10.48 | 0.02 | 9.87 | |||
Overexpression | 113 | 39.04 | 46.05 | ||||
Weak expression | 87 | 56.27 | 60.90 | ||||
Model | 0.00 | 21.76 | 0.00 | 21.34 | |||
High risk | 95 | 37.66 | 44.46 | ||||
Low risk | 105 | 53.91 | 59.27 |
- Citation: Zhang J, Piao HY, Wang Y, Lou MY, Guo S, Zhao Y. Development and validation of a three-long noncoding RNA signature for predicting prognosis of patients with gastric cancer. World J Gastroenterol 2020; 26(44): 6929-6944
- URL: https://www.wjgnet.com/1007-9327/full/v26/i44/6929.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i44.6929